IHJ-501

N/A

Report date: 2025/01/26 18:48:05

Base Information

Drug NameIHJ-501

Drug Alias NameiPSC-derived CD82-positive myocardial precursor cell therapy (intracardiac) (iHeart Japan)induced pluripotent stem cell-derived myocardial precursor cell therapy (intracardiac) (iHeart Japan)IHJ-501

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiogenic potential stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesiHeart Japan Corp

China Registration ClassN/A

Develop Information

Active CompaniesiHeart Japan Corp

Inactive CompaniesN/A

Active IndicationsHeart Failure

Inactive IndicationsN/A

Other Information

ATC CodeN/A